Note: At a fixed rate of supplemental oxygen flow, the inhaled oxygen concentration will vary, depending on where the oxygen is introduced, the pressure settings, patient breathing pattern, mask selection, and leak rate.

•Do not use the S8 Series II if there are obvious external defects or unexplained changes in performance.

•Do not open the S8 Series II case. There are no user serviceable parts inside. Repairs and internal servicing should only be performed by an authorized service agent.

•Explosion hazard—do not use in the vicinity of flammable anesthetics.

CAUTIONS

! • At low pressures, the flow through the exhalation ports of your mask may not clear all exhaled gas from the tubing. Some rebreathing may occur.

• The airflow for breathing produced by this device can be as much as 11ºF (6ºC) higher than the temperature of the room. Caution should be exercised if the room temperature is warmer than 90ºF (32ºC).

• When AC mains power (100–240V AC) is not available, always use a ResMed DC-12 converter. (The DC-12 converter is available as an optional accessory. It is not supplied with all models.)

Note: The above are general warnings and cautions. Specific warnings, cautions, and notes appear with the relevant instructions in the manual.

English

General Warnings and Cautions

15

Page 16 Page 18
Page 17
Image 17
ResMed S8 Escape II Auto, S8 Series II manual General Warnings and Cautions
Page 16 Page 18

S8 Escape II Auto, S8 Series II specifications

The ResMed S8 Series II is a prominent line of CPAP (Continuous Positive Airway Pressure) devices designed to treat obstructive sleep apnea effectively. One of the standout models within this series is the S8 AutoScore II, which has been engineered to adapt to varying patient needs with precision and comfort.

A key feature of the S8 AutoScore II is its AutoSet technology, which continuously monitors a patient's breathing patterns throughout the night. This innovation allows the device to automatically adjust the pressure delivered based on real-time data. As a result, users benefit from personalized therapy, ensuring that they receive the optimal level of air pressure needed at any given moment while they sleep.

The S8 AutoScore II also boasts an intelligent ResMed algorithm, which enhances its ability to differentiate between obstructive and central apneas. This specificity not only improves treatment efficacy but also contributes to increased patient comfort, minimizing the chances of unnecessary pressure increases that could lead to discomfort or disturbances during sleep.

Another notable aspect of the S8 AutoScore II is its user-friendly interface. The device features an intuitive LCD screen that displays essential information and settings, making it straightforward for users to navigate through various options. This simplicity is particularly beneficial for new users who may find CPAP therapy overwhelming.

In addition to its advanced technological features, the S8 Series II incorporates a compact and lightweight design, making it highly portable. Users can easily transport the device for travel or overnight stays, promoting compliance with their therapy even when away from home.

Moreover, the S8 AutoScore II comes equipped with a SmartStart function, which allows the device to automatically commence therapy once the user breathes into the mask. This feature enhances user convenience, eliminating the need for manual adjustments once the device is in place.

The S8 Series II also emphasizes quiet operation, ensuring that the device does not disturb the user or their partner during the night. Low noise levels and a comfortable fit contribute to an overall positive sleeping experience, which is crucial for the success of CPAP therapy.

Overall, the ResMed S8 Series II, particularly the S8 AutoScore II model, represents a blend of cutting-edge technology, user-centric design, and versatile functionality. These characteristics make it a reliable choice for individuals seeking effective management of obstructive sleep apnea while prioritizing comfort and convenience in their treatment journey.
Top Page Image Contents